Rajni Kannan, BS, MS, RN, APN-BC, discusses the management of patients receiving combination immunotherapy.
Rajni Kannan, BS, MS, RN, ANP-BC, of NYU Langone—Perlmutter Cancer Center—discusses the importance of keeping up with patients who have received combination immunotherapy.
Combination immunotherapy can often have intense and quick-acting side effects, increasing the need for careful patient management. Rather than solely bringing patients back into the center for visits, nurses can use smartphones to keep in touch with patients, who can send photographs of rashes or other changes, for example. The key is strong patient education, to make patients aware of the importance of reporting their side effects as soon as possible.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.